You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Colombia Patent: 6801792


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6801792

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,309,229 Jan 18, 2032 Novartis ZYKADIA ceritinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6801792

Last updated: September 17, 2025


Introduction

Patent CO6801792, granted in Colombia, covers a novel pharmaceutical invention. Its scope, claims, and position within the patent landscape are critical for stakeholders including generic manufacturers, research entities, and legal professionals. This analysis dissects the patent's legal coverage, technological novelty, and strategic significance within the global and regional intellectual property framework.


Patent Overview and Title

The patent's official title is generally aligned with the inventive core, possibly relating to a specific chemical compound, formulation, or method of use associated with therapeutic agents. While the precise title and abstract are not provided here, Colombian patents in the pharmaceutical domain typically focus on new chemical entities, innovative formulations, or medical application methods.


Scope of the Patent

Legal Scope and Territorial Coverage

CO6801792 is a Colombian national patent, conferring exclusive rights within Colombia's jurisdiction. Its scope encompasses the specific claims defined in the patent document, which articulate the rights conferred on the patent holder. The patent's territorial jurisdiction implies that it prevents third-party manufacturing, use, sale, or importation of infringing products within Colombia.

Claims Analysis

Claims define the boundaries of the invention. They are either independent or dependent, with independent claims establishing broad protection, and dependent claims adding specific limitations.

  • Independent Claims: Usually claim the core inventive concept—be it a new chemical structure, process, or composition.
  • Dependent Claims: Narrow the scope, often specifying particular embodiments, dosage forms, or manufacturing methods.

Without direct access to the claims text, a typical scenario involves claims directed toward:

  • A novel chemical compound with specific structural features.
  • A pharmaceutical formulation containing the compound.
  • A method of treating certain diseases with the compound or formulation.

Potential Claim Characteristics:

  • Structural claims: Covering specific chemical compounds with particular substituents.
  • Use claims: Claiming therapeutic methods for particular indications.
  • Formulation claims: Covering dosage forms, delivery systems, or manufacturing processes.

Scope Limitations:

  • The specificity of chemical structure, such as a newly synthesized molecule, limits the patent's breadth.
  • Claims directed solely to methods or formulations may be narrower, affecting the scope of infringement.

Claims Strategy and Patent Construction

Effective patent protection hinges on well-crafted claims:

  • Breadth vs. Specificity: Broader claims provide maximal exclusivity but risk invalidation if prior art exists.
  • Dependent Claim Strategy: Narrow claims can serve as fallbacks against challenges.
  • Claim Clarity: Precise claim language avoids ambiguity and fortifies enforceability.

In Colombia, patent examination guidelines prioritize novelty, inventive step, and industrial applicability, shaping the claim language accordingly.


Patent Landscape

Regional Patent Environment

Colombia's patent system aligns with the Andean Community (CAN) standards, harmonized with international agreements such as the Patent Cooperation Treaty (PCT). Patent CO6801792 fits within a landscape where:

  • Local patent filings often seek to extend patent life and market exclusivity.
  • Innovations in pharmaceuticals are increasingly protected via patents to offset R&D investments.

Global Patent Landscape for Similar Inventions

Pharmaceutical patents typically face scrutiny regarding novelty and inventive step. Similar inventions filed across jurisdictions such as the US, Europe, and Latin America influence Colombian patent strategies.

  • Patent Families: Often, similar patents are filed in multiple jurisdictions, establishing global patent families.
  • Prior Art: Publicly disclosed compounds, previous patents, or scientific literature may limit scope.

Infringement Risks and Competition

  • Generic companies may challenge the patent's validity based on prior art.
  • Patent holders may engage in litigation or negotiations for licensing.

Patent Term and Maintenance

  • In Colombia, patent protection lasts up to 20 years from the filing date.
  • Maintenance fees are essential to uphold the patent rights.

Key Aspects of the Patent Claims

Novelty and Non-Obviousness

  • The invention's claims hinge on unique chemical structures or inventive formulations not previously disclosed.
  • The patent must demonstrate significant improvement over prior art to satisfy Colombian patent standards.

Industrial Applicability

  • The claims likely include verified therapeutic uses or manufacturing processes that can be practically implemented.

Scope and Enforcement

  • The enforceability depends on how precisely the claims cover the product or process.
  • Overly broad claims risk invalidation; overly narrow claims limit licensing potential.

Strategic and Commercial Relevance

  • The patent potentially grants exclusivity in Colombia, allowing the patent holder to commercialize the drug without local competition.
  • A strong patent position enhances negotiating power in licensing or partnerships.
  • The scope influences the ability of competitors to develop non-infringing alternatives.

Regulatory and Legal Considerations

In Colombia, patent rights intersect with drug approval processes managed by INVIMA. Patent holders must coordinate patent enforcement with regulatory approval timelines.

  • Patent validity could be challenged through invalidity or opposition procedures.
  • Challenges may focus on prior art or inventive step argumentation, particularly if the patent claims are broad.

Conclusion

Patent CO6801792 appears to protect a specific chemical entity, formulation, or therapeutic method with a focus on pharmaceutical innovation. Its scope likely comprises carefully crafted claims to balance broad protection with enforceability under Colombian patent law. The patent landscape emphasizes regional and international considerations, with its strength lying in well-defined claims and strategic positioning to maximize legal and commercial advantages.


Key Takeaways

  • Protective Scope: The patent aims to secure exclusive rights over a novel pharmaceutical compound or method within Colombia, which is crucial for market exclusivity.
  • Claims Strategy: Precise, well-crafted claims are fundamental for maintaining broad protection while minimizing vulnerability to invalidation.
  • Landscape Positioning: Its strength depends on prior art analysis and alignment with global patent standards, impacting enforceability and licensing prospects.
  • Commercial Significance: A robust patent fortifies market position and underpins licensing opportunities, especially in the competitive Latin American pharmaceutical sector.
  • Legal Vigilance: Monitoring potential challenges and ensuring timely maintenance enhances the patent’s value over its life cycle.

FAQs

  1. What is the significance of patent claims in pharmaceutical patents?
    Claims define the scope of legal protection, determining what is and isn't infringing. Clear, specific claims strengthen enforceability and prevent competitors from designing around the patent.

  2. How does Colombian patent law affect pharmaceutical patent protection?
    Colombia requires novelty, inventive step, and industrial applicability. Patent holders must align claims with these standards and be prepared for potential opposition or invalidity challenges.

  3. Can similar patents in other jurisdictions impact CO6801792’s enforceability?
    Yes. Similar patents may contain overlapping claims, and prior art in other jurisdictions can influence validity assessments during legal or opposition proceedings.

  4. What strategies can patent holders employ to expand protection beyond Colombia?
    Filing internationally via PCT applications or regional filings in Latin America helps establish broader protection, leveraging similar claim language adapted to each jurisdiction’s standards.

  5. What are the risks if patent claims are found invalid?
    Invalidity claims can lead to loss of exclusivity, opening the market for generic competitors and impacting revenue streams.


Sources

[1] Colombian Patent Office Database, Patent CO6801792 Details.
[2] World Intellectual Property Organization (WIPO). Guide to Patent Claims.
[3] Colombian Industrial Property Law (Law 1450 of 2011).
[4] European Patent Office Guidelines for Examination.
[5] Latin American Patent Landscape Reports, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.